Quality of Life Measures in Elderly Patients with Chronic Obstructive Pulmonary Disease: Japanese Perspectives

  • K. Kida
  • T. Motegi
  • T. Ishii
  • K. Yamada
Reference work entry


 Chronic obstructive pulmonary disease (COPD) is a common disease with increasing prevalence, which tends to show accelerated progression in patients over 65 years old, consequently becoming a major public health problem among elderly populations worldwide. Patients experience a progressive deterioration up to end-stage COPD, characterized by airflow limitation, a severely limited and declining performance status with  chronic respiratory failure, advanced age, and various  comorbidities due to systemic manifestations. These are mainly attributed to a delay in diagnosis, leading to additional and unexpected comorbidities during the clinical course. These comorbidities can be divided into three major groups: one is a COPD-specific group such as lung cancer; the second group comprises comorbidities generally observed at an advanced age, such as aspiration pneumonia or cognitive impairment; and the third group is made up of a mixture of these, such as osteoporosis, stroke, or ischemic heart disease.

The majority of elderly patients with COPD are managed by primary care physicians who still may not be aware of the recent clinical guidelines; thus, these patients are unlikely to receive proper management in the long term. The culmination of a delayed clinical diagnosis and poor management results in the reduction of activities of daily living ( ADL), repeated exacerbations, a poor  quality of life (QOL), and high mortality rate in the elderly with COPD, leading to an increasing socio-economic burden. The management of COPD in elderly patients requires multidisciplinary holistic care with a comprehensive approach based on home respiratory care. In this regard, the role of primary care cannot be overestimated, and cooperation between specialist groups and primary care physicians, along with the support of local health care professionals, is critical. Therefore, treatment improvements and a team approach regarding COPD and its comorbidities are urgently needed in terms of health care for elderly COPD patients in our aging society.

We have described problems concerning elderly COPD patients through our experiences in Japan, particularly from the aspect of the health-related QOL and its perspectives.


Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Patient Home Oxygen Therapy Home Mechanical Ventilation Japanese Respiratory Society 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


6-minute walking distance


pre-interview questionnaire with 11 questions


activities of daily living


airways questionnaire


American Thoracic Society


breathing problems questionnaire


chronic obstructive pulmonary disease


chronic respiratory questionnaire


forced expiratory volume in 1 s


gastroesophageal reflux disorders


Global initiative for Chronic Obstructive Lung Disease


home oxygen therapy


 home mechanical ventilation


health-related quality of life


instrumental activities of daily living


international classification of functioning,  disability, and health


international classification of impairments, disabilities, and handicaps


 long-term oxygen therapy


lung volume reduction surgery


oxygen cost diagram


obstructive sleep apnea syndrome


quality of life


quality of life for respiratory illness questionnaire

QOL scale

questionnaires for quality of life using a linear analog scale


self-administered standardized


36-item short-form health survey


St George’s respiratory questionnaire


sickness impact profile


upper respiratory infection


visual analogue scale


World Health Organization


  1. Agusti AGN. (2005). Proc Am Thorac Soc. 2: 367–370.PubMedCrossRefGoogle Scholar
  2. American Thoracic Society. (1997). Am J Respir Crit Care Med. 152 (Suppl.): S77–S121.Google Scholar
  3. American Thoracic Society/European Respiratory Society Task Force. Standards for the Diagnosis and Management of Patients with COPD [Internet]. Version 1.2. American Thoracic Society; 2004 [updated 2005 September 8], New York. Available at: http://www.thoracic.org/go/copd.
  4. Anderson GF. (2005). N Engl J Med. 353: 305–309.PubMedCrossRefGoogle Scholar
  5. Anzueto A, Sethi S, Martinez FJ. (2007). Proc ATS. 4: 554–564.Google Scholar
  6. Babbott SF, Bigby JA, Day SC, Dugdale DC, Fihn SD, Kapoor WN, McMahon LF Jr, Rosenthal GE, Sinsky CA. (2006). Available at: www.sgim.org/pdf/SGIMReports/BRPFinalReport71106.pdf/ Accessed on 14 Mar 2008.
  7. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group. (2007). Lancet. 370: 741–750.PubMedCrossRefGoogle Scholar
  8. Carr AJ, Gibson B, Robinson PG. (2001). BMJ. 322: 1240–1243.PubMedCrossRefGoogle Scholar
  9. Casas, A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, Alonso A, del Pozo F, de Toledo P, Anto JM, Rodriguez-Roisin R, Decramer M. (2006). Eur Respir J. 28: 123–130.PubMedCrossRefGoogle Scholar
  10. Cassano P, Fava M. (2002). J Psychosom Res. 53: 849–857.PubMedCrossRefGoogle Scholar
  11. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF. (2008). American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD Eur Respir J. 31: 416–469.PubMedCrossRefGoogle Scholar
  12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. (1987). J Chronic Dis. 40: 373–383.PubMedCrossRefGoogle Scholar
  13. Fletcher C, Peto R. (1977). Br Med J. 1: 1645–1648.PubMedCrossRefGoogle Scholar
  14. Folestein MF, Folestein SE, McHugh PR. (1975). J Psychiatr Res. 12: 189–198.CrossRefGoogle Scholar
  15. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C. (2004). Respirology. 9: 458–465.PubMedCrossRefGoogle Scholar
  16. Global Initiative for Chronic Obstructive Lung Disease. (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD Updated 2007. Available at: http://www.goldcopd.org/
  17. Hiratuka T, Kida K. (1993). Int Med. 32: 836–836.Google Scholar
  18. Hyland ME, Sodergren SC. (2005). In: Ahmedzai SH, Muers MF (ed.) Supportive Care in Respiratory Disease. Oxford University Press, New York, pp. 57–66.Google Scholar
  19. Ikegami N, Campbell JC. (1995). N Engl J Med. 333: 1295–1299.PubMedCrossRefGoogle Scholar
  20. Ionescu AA, Schoon E. (2003). Eur Respir J. 22: 64S–75S.CrossRefGoogle Scholar
  21. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. (1992). Am Rev Respir Dis. 145: 1321–1327.PubMedGoogle Scholar
  22. Katsura H, Kida K. (2002). Chest. 122: 1949–1955.PubMedCrossRefGoogle Scholar
  23. Katsura H, Yamada K, Kida K. (2003). J Am Geriatr Soc. 51: 1131–1135.PubMedCrossRefGoogle Scholar
  24. Kida K, Motegi T. (2000). Kokyu. 19: 1235–1247.(in Japanese)Google Scholar
  25. Kida K, Wakabayashi R, Mizuuchi T, Murata A. (2006). Intern Med. 45: 1201–1207.PubMedCrossRefGoogle Scholar
  26. Liang J, Asano H, Bollen KA, Kahana EF, Maeda D. (1987). J Gerontol. 42: 37–43.PubMedGoogle Scholar
  27. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. (2006). Global Burden of Disease and Risk Factors. The World Bank, Washington.CrossRefGoogle Scholar
  28. Lutz W, Sanderson W, Scherbov S. (2008). Nature. 451: 716–719.PubMedCrossRefGoogle Scholar
  29. Lynn J. (2001). JAMA. 285: 925–932.PubMedCrossRefGoogle Scholar
  30. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD, Hogg J, Ries AL, Han M, Fishman AP, Make B, Hoffman EA, Mohsenifar Z, Wise R; National Emphysema Treatment Trial Research Group. (2007). Am J Respir Crit Care Med. 176: 243–252.PubMedCrossRefGoogle Scholar
  31. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA; TORCH Clinical Endpoint Committee. (2007). Thorax. 62: 411–415.PubMedCrossRefGoogle Scholar
  32. McGavin CR, Artvinli M, Naoe H, McHardy GJ. (1978). Br Med J. 2: 241–243.PubMedCrossRefGoogle Scholar
  33. Ministry of Health, Labour and Welfare. (2005). Patient Survey.Google Scholar
  34. Ministry of Health, Labour and Welfare. (2006). Vital statistics.Google Scholar
  35. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. (2007). Lancet. 370: 851–858.PubMedCrossRefGoogle Scholar
  36. Patel V, Araya R, Bolton P. (2004). Trop Med Int Health. 9: 539–541.PubMedCrossRefGoogle Scholar
  37. Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ; COPD Questionnaire Study Group. (2006). Chest. 129: 1531–1539.PubMedCrossRefGoogle Scholar
  38. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. (2007). Ann Intern Med. 147: 633–638.PubMedGoogle Scholar
  39. Sanders MH, Newman AB, Haggerty CL, Redline S, Lebowitz M, Samet J, O'Connor GT, Punjabi NM, Shahar E. (2003). Am J Respir Crit Care Med. 167: 7–14.PubMedCrossRefGoogle Scholar
  40. Schünemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Griffith LE, Bayoumi AM, Austin P, Guyatt GH. (2006). Qual Life Res. 15: 1–14.PubMedCrossRefGoogle Scholar
  41. Seyama K, Nukiwa T, Takabe K, Takahashi H, Miyake K, Kira S. (1991). J Biol Chem. 266: 12627–12632.PubMedGoogle Scholar
  42. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators. (2007). JAMA 297: 1197–1206.PubMedCrossRefGoogle Scholar
  43. The Japanese Respiratory Society. (2004). Guidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease), 2nd ed. Available at: http://www.jrs.or.jp/home/modules/english/index.php?content_id = 15.
  44. The Japanese Respiratory Society. (2006). Japanese White Paper on Home Respiratory Care. Available at: http://www.jrs.or.jp/home/modules/english/index.php?content_id = 15.
  45. Voelker R. (1999). JAMA. 281: 1262.CrossRefGoogle Scholar
  46. Wakabayashi R, Katsura H, Yamada K, Motegi T, Omata M, Nishimura N, Goto R, Kida K. (2003). Eur Respir J. 22: 169s.Google Scholar
  47. Yohannes AM. (2005). Br J Community Nurs. 10: 42–46.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • K. Kida
    • 1
  • T. Motegi
    • 1
  • T. Ishii
    • 1
  • K. Yamada
    • 1
  1. 1.Department of Pulmonary MedicineInfection, and Oncology, Respiratory Care Clinic, Nippon Medical SchoolTokyoJapan

Personalised recommendations